KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Notes Payables (2022 - 2025)

Opko Health filings provide 3 years of Notes Payables readings, the most recent being $101.2 million for Q1 2025.

  • On a quarterly basis, Notes Payables rose 59454.12% to $101.2 million in Q1 2025 year-over-year; TTM through Mar 2025 was $101.2 million, a 59454.12% increase, with the full-year FY2024 number at $170000.0, changed N/A from a year prior.
  • Notes Payables hit $101.2 million in Q1 2025 for Opko Health, up from $170000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $101.2 million in Q1 2025 to a low of $170000.0 in Q1 2024.
  • Median Notes Payables over the past 3 years was $170000.0 (2024), compared with a mean of $25.1 million.
  • The widest YoY moves for Notes Payables: up 59454.12% in 2025, down 59454.12% in 2025.
  • Opko Health's Notes Payables stood at $3.0 million in 2022, then crashed by 94.43% to $170000.0 in 2024, then surged by 59454.12% to $101.2 million in 2025.
  • The last three reported values for Notes Payables were $101.2 million (Q1 2025), $170000.0 (Q4 2024), and $170000.0 (Q3 2024) per Business Quant data.